Although the study suggests encouraging anti-tumor effects of gomisin B in MYCN-amplified NB cells, further exploration is required to understand its actual mechanism in regulating ESR1 and its interactions with chemotherapy drugs. The gene discussed is MYCN; the disease is neuroblastoma.